← Back to TCM Global · All articles
2026-10-23
For any natural compound, the commercial question is never 'can we make it?' — labs have made rare ginsenosides for years. It is: can you make kilograms of it, at purity, repeatedly, at a price a product can carry?
Giant Biogene's reported hundred-kilogram-scale production of five rare saponins (Rk3, Rh4, Rk1, Rg5, CK) clears exactly that threshold.
Laboratory production of rare saponins runs to thousands of yuan per gram. Industrial-scale conversion and purification bends the curve toward ingredient-grade economics — the difference between a compound mentioned in papers and a compound listed on product labels.
Product design requires dosing: a serum that promises meaningful CK content needs grams per thousand units. Sub-scale supply forces 'fairy dust' formulas — trace actives for label claims. Hundred-kilogram capacity enables honest dosing.
Brands, retailers and international buyers need supply agreements — volume commitments with specifications. No contract is written on flask-scale supply. Scale is what makes an ingredient bankable.
Registrations (like CK's) typically require documented manufacturing consistency — batch data at production scale. Scale and registration reinforce each other.
The industry's routes (combined, typically):
Academic teams (like the catalysis research presented at the Big Food Concept forum) keep improving the chemistry; corporate teams industrialize it.
Rare saponins just crossed their Industrial Revolution. The hundred-kilogram threshold converts a decade of chemistry into a supply chain — and supply chains are where consumer industries are actually built.
Explore more Eastern wellness wisdom at TCM Global.